Innate Pharma Market Cap

Innate Pharma has a market cap or net worth of €130.28 million as of March 6, 2026. Its market cap has decreased by -30.30% in one year.

Market Cap

130.28M

Enterprise Value

97.28M

Revenue

12.64M

Ranking

n/a

PE Ratio

n/a

Stock Price

€1.39

Market Cap Chart

Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 130.28M, an increase of 16,346.66%. That is a compound annual growth rate of 30.16%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	130.28M	-11.78%
Dec 31, 2025	147.67M	-7.67%
Dec 31, 2024	159.94M	-24.29%
Dec 29, 2023	211.24M	-19.93%
Dec 30, 2022	263.84M	-24.98%
Dec 31, 2021	351.67M	28.64%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sensorion	128.25M
Adocia	126.57M
MaaT Pharma	131.34M
ABIONYX Pharma	114.83M
OSE Immunotherapeutics	91.03M
Transgene	233.30M
Valerio Therapeutics Société anonyme	69.42M
Cellectis	239.40M

Market Cap Rankings